SCHEMBL515846

SCHEMBL515846

Oc1ccc(C(c2ccc(O)cc2)(c2ccc(O)cc2)C(CC2CO2)(CC2CO2)CC2CO2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.35
ESR2 Q92731 9/20 0.35
HPGD P15428 3/20 0.34
TSHR P16473 3/20 0.34
CYP3A4 P08684 2/20 0.34
LMNA P02545 1/20 0.34
TYR P14679 1/20 0.34
AR P10275 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
HTR6 P50406 1/20 0.34
ESRRG P62508 1/20 0.34
SLC6A3 Q01959 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045334 0.81 MEN1 (0.42) HPGDTSHRCYP3A4LMNATP53
SCHEMBL452064 0.78 ESR2 (0.43) ESR1ESR2HPGDTSHRCYP3A4
SCHEMBL7608279 0.69 HIF1A (0.47) ESR1ESR2HPGDTSHRCYP3A4
SCHEMBL16332237 0.69 ALDH1A1 (0.44) ESR1ESR2HPGDTSHRCYP3A4
Glycidol SCHEMBL20637749 0.69 ESR1 (0.50) ESR1ESR2HPGDTSHRCYP3A4
Bisphenol A SCHEMBL9703935 0.69 ESR1 (0.57) ESR1ESR2HPGDTSHRCYP3A4
SCHEMBL21632749 0.69 ALDH1A1 (0.34) HSD17B10MAPTMEN1KMT2AALDH1A1
SCHEMBL950169 0.68 ESR2 (0.49) ESR1ESR2HPGDTSHRCYP3A4
Bisphenol A SCHEMBL442235 0.68 ESR1 (0.55) ESR1ESR2HPGDTSHRCYP3A4
Hydroquinone SCHEMBL11142442 0.67 ALDH1A1 (0.62) ESR1ESR2HPGDTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120029116-A1 CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS TRILLION SCIENCE, INC. (US) 2012-02-02 US disclosed
US-8084553-B2 Curable adhesive compositions, process, and applications TRILLION SCIENCE, INC. (US) 2011-12-27 US disclosed
US-20090181165-A1 Curable adhesive compositions, Process, and applications TRILLION SCIENCE, INC. (US) 2009-07-16 US disclosed
WO-2009089314-A1 CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS TRILLION SCIENCE, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029116-A1 CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS RBX1, SUZ12, CDH1 ESR1 121/4885ESR2 544/4885HPGD 1117/4885
US-20090181165-A1 Curable adhesive compositions, Process, and applications RBX1, SUZ12, CDH1 ESR1 121/4885ESR2 544/4885HPGD 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.